Cargando…
Suppression of the gut microbiota–bile acid–FGF19 axis in patients with atrial fibrillation
This study aimed to investigate the role of the gut microbiota (GM)–bile acid (BA)–fibroblast growth factor (FGF) 19 axis in patients with atrial fibrillation (AF). Gut bacterial metabolisms of BAs were determined in an AF metagenomic dataset. The composition of faecal BAs pools was characterized by...
Autores principales: | Zuo, Kun, Fang, Chen, Gao, Yuanfeng, Fu, Yuan, Wang, Hongjiang, Li, Jing, Zhong, Jiuchang, Yang, Xinchun, Xu, Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10623955/ https://www.ncbi.nlm.nih.gov/pubmed/37186335 http://dx.doi.org/10.1111/cpr.13488 |
Ejemplares similares
-
Disordered gut microbiota and alterations in metabolic patterns are associated with atrial fibrillation
por: Zuo, Kun, et al.
Publicado: (2019) -
Aggravated Gut Microbiota and Metabolomic Imbalances Are Associated with Hypertension Patients Comorbid with Atrial Fibrillation
por: Fang, Chen, et al.
Publicado: (2022) -
Alterations of gut viral signals in atrial fibrillation: complex linkage with gut bacteriome
por: Zuo, Kun, et al.
Publicado: (2022) -
The Impact of Sleep Disturbance on Gut Microbiota, Atrial Substrate, and Atrial Fibrillation Inducibility in Mice: A Multi-Omics Analysis
por: Zuo, Kun, et al.
Publicado: (2022) -
Association between Gut Microbiota Dysbiosis and the CHA2DS2-VASc Score in Atrial Fibrillation Patients
por: Fang, Chen, et al.
Publicado: (2022)